Michelle Fransen Shares A Historical Review on Plasma-Derived Medicinal Products
Michelle Fransen, Director, Lead for Study Management at Plasma Protein Therapeutics Association (PPTA), shared on LinkedIn:
”I am thrilled to share that Dr. Toby Simon and I had our article, “Source plasma apheresis and plasma-derived medicinal products: a historical review” published in the most recent issue Annals of Blood.
This paper, which can be found here, outlines the history of plasmapheresis and PDMP manufacturing which spans more than a century of scientific and clinical innovation.
We believe that understanding this history is more than academic—it underscores how continued innovation, strong regulatory oversight, and a focus on donor health are essential to sustaining a global plasma supply and advancing care for patients with immune deficiencies, coagulation disorders, and other rare diseases.”
Read the full article here.
Article: Source plasma apheresis and plasma-derived medicinal products: a historical review
Authors: Michelle Fransen, Toby Simon
Stay updated on all scientific advances with Hemostasis Today.
-
Jun 10, 2026, 14:52David Ferreira: Standardizing Thrombin Generation Testing in Portugal and Spain
-
Jun 10, 2026, 14:39Azlyat Mahmoud: Neuro-Hematology – Where Blood Disorders Meet Neurological Science
-
Jun 10, 2026, 13:22Lee Peter Bee: Silent mtDNA Mutations and the Secret Life of Ageing Clon
-
Jun 10, 2026, 13:19Abdul Mannan: A New DVT on Warfarin Is Not an INR Problem First
-
Jun 10, 2026, 13:06Ammar Alsughayir: Universal Access to Safe Blood – The 2026-2030 Action Framework
-
Jun 10, 2026, 13:01Tetsumei Urano: Promoting Movement and Health at APSTH 2026
-
Jun 10, 2026, 12:54Noemy E. Diaz-Burgos: Taking Care of Yourself First
-
Jun 10, 2026, 12:53David McIntosh: Australia Celebrates National Blood Donor Week
-
Jun 10, 2026, 12:43Anas Nasir: From the Bench to Digital Pathology